Results 1 to 10 of about 12,072 (259)

Assessing the Acceptability and Feasibility of Five Cycles of Seasonal Malaria Chemoprevention in Côte d’Ivoire [PDF]

Tropical Medicine and Infectious Disease
Seasonal malaria chemoprevention (SMC) is a strategy recommended by the World Health Organization for children aged 3–59 months in the Sahel and sub-Sahel regions where malaria transmission is seasonal.
Orphée Kangah, Issaka Zongo, Alassane Haro, William Yavo   +3 more
doaj   +5 more sources

Dihydroartemisinin-piperaquine effectiveness for seasonal malaria chemoprevention in settings with extended seasonal malaria transmission in Tanzania [PDF]

Scientific Reports
Effectiveness of dihydroartemisinin-piperaquine (DP) as seasonal malaria chemoprevention (SMC) was assessed in Nanyumbu and Masasi Districts. Between March and June 2021, children aged 3–59 months were enrolled in a cluster randomized study.
Richard Mwaiswelo, Billy Ngasala, Frank Chaky, Fabrizio Molteni, Ally Mohamed, Samwel Lazaro, Bushukatale Samwel, Bruno P. Mmbando   +7 more
doaj   +7 more sources

Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention [PDF]

New England Journal of Medicine, 2021
BACKGROUND: Malaria control remains a challenge in many parts of the Sahel and sub-Sahel regions of Africa. METHODS: We conducted an individually randomized, controlled trial to assess whether seasonal vaccination with RTS,S/AS01E was noninferior to ...
Daniel Chandramohan, Issaka Zongo, Issaka Sagara, Matthew Cairns, Rakiswendé-Serge Yerbanga, Modibo Diarra, Frédéric Nikièma, Amadou Tapily, Frédéric Sompougdou, Djibrilla Issiaka, Charles Zoungrana, Koualy Sanogo, Alassane Haro, Mahamadou Kaya, Abdoul-Aziz Sienou, Seydou Traoré, Almahamoudou Mahamar, Ismaila Théra, Kalifa Diarra, Amagana Dolo, Irene Kuepfer, Paul Snell, Paul Milligan, Christian F. Ockenhouse, Opokua Ofori‐Anyinam, Halidou Tinto, Abdoulaye Djimdé, Jean‐Bosco Ouédraogo, Alassane Dicko, Brian Greenwood   +29 more
core   +9 more sources

Evaluating the effectiveness and cost-effectiveness of integrating mass drug administration for helminth control with seasonal malaria chemoprevention in Ghanaian children: Protocol for a cluster randomised controlled trial. [PDF]

Trop Med Int Health
Abstract Objectives To evaluate the effectiveness and cost‐effectiveness of integrating seasonal malaria chemoprevention (SMC) with mass drug administration for helminth control among school‐aged children living in communities where the burden of malaria and helminths is high in Ghana, West Africa.
Afolabi MO, Adu-Gyasi D, Paintain L, Tawiah T, Ali MS, Greenwood B, Asante KP.   +6 more
europepmc   +4 more sources

Household-level effects of seasonal malaria chemoprevention in the Gambia [PDF]

Communications Medicine, 2023
Background In 2022 the WHO recommended the discretionary expansion of the eligible age range for seasonal malaria chemoprevention (SMC) to children older than 4 years.
Seyi Soremekun, Bakary Conteh, Abdoullah Nyassi, Harouna M. Soumare, Blessed Etoketim, Mamadou Ousmane Ndiath, John Bradley, Umberto D’Alessandro, Teun Bousema, Annette Erhart, Marta Moreno, Chris Drakeley   +11 more
doaj   +6 more sources

Prevalence of asymptomatic parasitaemia among household members of children under seasonal malaria chemoprevention coverage and comparison of the performance of standard rapid diagnostic tests versus ultrasensitive RDT for the detection of asymptomatic parasitaemia in Nanoro, Burkina Faso. [PDF]

Parasitol Res
Asymptomatic carriers of Plasmodium falciparum represent important parasite reservoirs maintaining malaria transmission in the community. This study aimed on the one hand to screen the other household members living with children under seasonal malaria ...
Kambou SAE, Millogo KS, Sondo P, Kabore B, Kouevi AFC, Bouda I, Rouamba T, Derra K, Tahita MC, Ilboudo H, Rouamba E, Tougri G, Otienoburu SD, Dhorda M, Bamba S, Guerin PJ, Tinto H.   +16 more
europepmc   +6 more sources

Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo [PDF]

Malaria Journal, 2023
Background Malaria is the leading cause of morbidity and mortality among infants and children under-five in sub-Saharan Africa. In the Sahel, seasonal malaria chemoprevention (SMC) is delivered door-to-door in monthly cycles.
Taiwo Ibinaiye, Olusola Oresanya, Chibuzo Oguoma, Adaeze Aidenagbon, Olabisi Ogunmola, Christian Rassi, Sol Richardson   +6 more
doaj   +5 more sources

Effect of seasonal malaria chemoprevention on incidence of malaria among children under five years in Kotido and Moroto Districts, Uganda, 2021: time series analysis [PDF]

Malaria Journal
Background Seasonal malaria chemoprevention (SMC) refers to monthly administration of full treatment courses of anti-malarial medicine to children
Andrew Kwiringira, Benon Kwesiga, Richard Migisha, Lilian Bulage, Daniel Kadobera, Damian Rutazaana, Julie R. Harris, Alex R. Ario, Julius Ssempiira   +8 more
doaj   +4 more sources

Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou) [PDF]

Malaria Journal
Background Among the several strategies recommended for the fight against malaria, seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine combination (SPAQ) targets children 3 months to 5 years in Sahel regions of Africa to
Innocent M. Ali, Isaac A. Manga, Akindeh M. Nji, Valery P. Tchuenkam, Peter Thelma Ngwa Neba, Dorothy F. Achu, Jude D. Bigoga, Babacar Faye, Cally Roper, Colin J. Sutherland, Wilfred F. Mbacham   +10 more
doaj   +4 more sources

Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trial. [PDF]

BMJ Open
Introduction Seasonal malaria chemoprevention (SMC) involves repeated administrations of sulfadoxine-pyrimethamine plus amodiaquine to children below the age of 5 years during the peak transmission season in areas of seasonal malaria transmission.
Moreno M, Barry A, Gmeiner M, Yaro JB, Sermé SS, Byrne I, Ramjith J, Ouedraogo A, Soulama I, Grignard L, Soremekun S, Koele S, Ter Heine R, Ouedraogo AZ, Sawadogo J, Sanogo E, Ouedraogo IN, Hien D, Sirima SB, Bradley J, Bousema T, Drakeley C, Tiono AB.   +22 more
europepmc   +4 more sources